• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希鲁诺姆,新型水蛭素样直接凝血酶抑制剂。

Hirunorms, novel hirudin-like direct thrombin inhibitors.

作者信息

Cappiello M, Vilardo P G, Del Corso A, Mura U

机构信息

Dipartimento di Fisiologia e Biochimica, Università di Pisa, Italy.

出版信息

Gen Pharmacol. 1998 Apr;30(4):565-8. doi: 10.1016/s0306-3623(97)00306-6.

DOI:10.1016/s0306-3623(97)00306-6
PMID:9522176
Abstract
  1. Hirunorms are new synthetic peptides designed to interact with thrombin in a similar way to the natural inhibitor hirudin. 2. Hirunorms are specific and efficient in vitro inhibitors of thrombin activity. 3. Hirunorms are potent anticoagulant and antithrombotic agents in in vivo experimental models devoid of hemorrhagic effects at doses that are active in preventing thrombosis.
摘要
  1. 希鲁诺姆是新合成的肽,其设计目的是以与天然抑制剂水蛭素类似的方式与凝血酶相互作用。2. 希鲁诺姆在体外是凝血酶活性的特异性高效抑制剂。3. 在体内实验模型中,希鲁诺姆是强效抗凝剂和抗血栓形成剂,在预防血栓形成的有效剂量下无出血作用。

相似文献

1
Hirunorms, novel hirudin-like direct thrombin inhibitors.希鲁诺姆,新型水蛭素样直接凝血酶抑制剂。
Gen Pharmacol. 1998 Apr;30(4):565-8. doi: 10.1016/s0306-3623(97)00306-6.
2
BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.BCH-2763是一种新型强效胃肠外凝血酶抑制剂,在动脉和静脉血栓形成的啮齿动物模型中是一种有效的抗血栓药物——与肝素、重组水蛭素、水蛭肽、伊诺加群和阿加曲班的比较。
Thromb Haemost. 1998 Feb;79(2):431-8.
3
Development of direct thrombin inhibitors in comparison with glycosaminoglycans.直接凝血酶抑制剂与糖胺聚糖的对比研究进展
Semin Thromb Hemost. 2001 Oct;27(5):523-30. doi: 10.1055/s-2001-17962.
4
Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.含α-酮酰胺过渡态模拟物的二价凝血酶抑制剂的合成、结构及构效关系
Protein Sci. 1996 Mar;5(3):422-33. doi: 10.1002/pro.5560050303.
5
Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.用于治疗动脉血栓形成的直接凝血酶抑制剂:比伐卢定与水蛭素之间的潜在差异。
Am J Cardiol. 1998 Oct 22;82(8B):12P-18P. doi: 10.1016/s0002-9149(98)00660-2.
6
Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis.在一种新型兔动静脉同时血栓形成模型中评估凝血酶抑制剂的疗效。
Thromb Haemost. 1998 Mar;79(3):656-62.
7
Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors.水蛭素模拟物的合理设计:多位点定向α-凝血酶抑制剂的合成与表征
J Med Chem. 1996 May 10;39(10):2008-17. doi: 10.1021/jm950898g.
8
[Natural and synthetic inhibitors of thrombin. I. Natural inhibitors].[凝血酶的天然和合成抑制剂。I. 天然抑制剂]
Ukr Biokhim Zh (1999). 1999 Jan-Feb;71(1):5-15.
9
Synthetic low-molecular weight thrombin inhibitors: the ideal antithrombotic drug? An introduction.
J Enzyme Inhib. 1995;9(1):1-2. doi: 10.3109/14756369509040676.
10
Direct thrombin inhibitors in cardiovascular disease.心血管疾病中的直接凝血酶抑制剂
Coron Artery Dis. 1997 Feb;8(2):105-11. doi: 10.1097/00019501-199702000-00007.